HPV-vaccination til kvinder

Translated title of the contribution: HPV vaccination for women

Lisa Maria Bæk Høgh*, Dina Overgaard Eriksen, Ina Marie Dueholm Hjorth, Anne Hammer

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

17 Downloads (Pure)


HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.
Translated title of the contributionHPV vaccination for women
Original languageDanish
Article numberV11210891
JournalUgeskrift for Læger
Issue number22
Pages (from-to)2143-2145
Number of pages3
Publication statusPublished - 23 May 2022


Dive into the research topics of 'HPV vaccination for women'. Together they form a unique fingerprint.

Cite this